1932年'木乃伊'电影海报
由鲍里斯·卡洛夫主演的木乃伊 em>是经典的恐怖片三部曲中的第一部。并且,这三部全都被人们认为是经典之作。而这张罕见的电影原创海报也被认为是经典之作,也是现存最昂贵的电影海报之一。这张海报是由通用广告艺术总监格罗斯卡罗伊所设计的石版画,并且这是限有的三张海报之一。它曾在1997年就被评定为最具价值的海报。根据预计,在10月31日时,当拍卖敲定时,它的历史将会继续改写。
由鲍里斯·卡洛夫主演的木乃伊 em>是经典的恐怖片三部曲中的第一部。并且,这三部全都被人们认为是经典之作。而这张罕见的电影原创海报也被认为是经典之作,也是现存最昂贵的电影海报之一。这张海报是由通用广告艺术总监格罗斯卡罗伊所设计的石版画,并且这是限有的三张海报之一。它曾在1997年就被评定为最具价值的海报。根据预计,在10月31日时,当拍卖敲定时,它的历史将会继续改写。
SOREL expands the Horizon collection by carrying the rugged DNA of its iconic Caribou boot across three silhouettes built for changing terrain and seasons. The Callsign Horizon Low GTX brings the concept closest to a sneaker, pairing waterproof GORE-TEX® construction with lightweight Livelyfoam cushioning and a Vibram XS Trek Evo outsole for everyday traction. Moving higher, the Daystorm Horizon GTX combines full-grain leather, GORE-TEX® waterproofing, and a rugged Vibram® lug outsole for everything from wet city streets to the trail. At the top of the lineup, the Caribou Horizon GTX modernizes SOREL's winter icon with 200 grams of insulation, seam-sealed leather, a GORE-TEX® membrane, and Caribou-inspired Vibram traction for snow, slush, and cold-weather exploration.
Presented by SOREL.
Arbor makes physician-prescribed GLP-1 weight loss treatment more accessible with transparent pricing that stays put, even as doses change. Plans start at $99/month for compounded semaglutide and $149/month for compounded tirzepatide, with no insurance, hidden fees, or membership costs required. The telehealth platform connects patients with licensed U.S. clinicians through a simple online assessment, with eligible prescriptions shipped free and each subscription covering medication, consultations, dose adjustments, and ongoing support. Board-certified physicians, dietitian-led nutrition guidance, and a 12-month money-back guarantee for eligible members round out a program designed to make medically supervised weight management simpler and more affordable.
Presented by Arbor.
Arbor is a technology platform; medical evaluations are conducted by independent licensed providers who determine whether treatment is appropriate. Compounded medications are not reviewed by the FDA for safety or effectiveness. Consultation requirements vary by state.